Western Pacific Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$118K Sell
210
-1
-0.5% -$641 0.12% 83
2025
Q4
$143K Buy
211
+22
+12% +$15K 0.14% 75
2025
Q3
$121K Sell
189
-145
-43% -$88K 0.12% 85
2025
Q2
$179K Buy
334
+31
+10% +$14.8K 0.17% 74
2025
Q1
$127K Buy
303
+101
+50% +$43.9K 0.12% 88
2024
Q4
$83.5K Buy
+202
New +$88.6K 0.07% 117

Other funds holding IDXX

Western Pacific Wealth Management's IDXX Position: Q1 2026 in Review

Western Pacific Wealth Management reduced its Idexx Laboratories (IDXX) stake by 0.47% in Q1 2026, selling an estimated $641 and leaving 210 shares worth $118K. The position accounts for 0.12% of the portfolio, ranked #83.

Western Pacific Wealth Management first reported a position in IDXX in Q4 2024 and has held it in 6 quarters since. The position peaked at $179K in Q2 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Western Pacific Wealth Management held 210 shares of Idexx Laboratories worth $118K as of Q1 2026.
  • Western Pacific Wealth Management sold 1 Idexx Laboratories share in Q1 2026, an estimated $641.
  • Idexx Laboratories made up 0.12% of Western Pacific Wealth Management's portfolio in Q1 2026, its #83 holding.
  • Western Pacific Wealth Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 6 quarters since.
  • Western Pacific Wealth Management's Idexx Laboratories position peaked at $179K in Q2 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Western Pacific Wealth Management's 13F filing for Q1 2026, filed 17 Apr 2026.